Assay Development Fragment Screening Pharmaceuticals Screening Hits 
Sygnature Discovery
JUNE 17, 2024
From hit finding and target engagement studies, to the characterisation of kinetic properties for late-stage candidate molecules, we believe that a biophysical approach complements other assays to deliver a fuller picture of binding behaviour to produce more effective therapeutics.
Drug Target Review
NOVEMBER 1, 2023
The team that I lead within the CCDD is called the Hit Discovery and Structural Design Team. We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. We can screen with many different formats and modalities.
Expert insights. Personalized for you.
52 
Let's personalize your content